Long-term chemotherapy of ovarian cancer: two case reports.
The treatment period of patients with advanced ovarian cancer is generally limited to about six months and maintenance chemotherapy is seldom used. The present report describes two women given chemotherapy continuously for several years with apparently good efficacy and acceptable toxicity.
Andersson
H
H
Department of Gynecologic Oncology, Sahlgrenska University Hospital, Gothenburg, Sweden.
Horvath
G
G
D000368:Aged; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D016190:Carboplatin / Q000008:administration & dosage; D002277:Carcinoma / Q000188:drug therapy* / Q000556:secondary / Q000601:surgery; D017024:Chemotherapy, Adjuvant; D003520:Cyclophosphamide / Q000008:administration & dosage; D004334:Drug Administration Schedule; D015251:Epirubicin / Q000008:administration & dosage; D017809:Fatal Outcome; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D008113:Liver Neoplasms / Q000556:secondary; D008134:Long-Term Care; D008525:Medroxyprogesterone / Q000008:administration & dosage; D008875:Middle Aged; D010051:Ovarian Neoplasms / Q000188:drug therapy* / Q000601:surgery; D010052:Ovariectomy; D010190:Pancreatic Neoplasms / Q000556:secondary
D015251:Epirubicin; D003520:Cyclophosphamide; D016190:Carboplatin; D008525:Medroxyprogesterone